
Robotic radical cystectomy is an operation to remove the urinary bladder using a robotic-assisted surgical system. It is used for selected patients with bladder cancer when bladder removal is an appropriate part of the treatment plan.
The surgeon controls the robotic instruments from a console. The system provides a magnified three-dimensional view and allows precise instrument movements in the pelvis. The robot does not operate independently: the surgeon performs and directs every surgical step.
After the bladder is removed, urine needs a new route out of the body. The operation therefore includes urinary diversion, such as an ileal conduit or, in selected patients, an orthotopic neobladder.
Robotic radical cystectomy may be considered for appropriately selected patients with muscle-invasive bladder cancer and for selected high-risk non-muscle-invasive disease when radical cystectomy is recommended.
Before deciding on surgery, the team reviews the biopsy, tumour stage, imaging, previous treatments, kidney function, general fitness and whether systemic treatment should be given before surgery. The decision should be made as part of an individual treatment plan, often involving a multidisciplinary team.
Robotic surgery is not suitable for every patient. Tumour extent, involvement of nearby structures, previous major pelvic surgery or radiotherapy, anatomy, medical fitness and the planned reconstruction may influence the safest approach.
The operation is performed under general anaesthesia. Small incisions are used to introduce the camera and robotic instruments into the abdomen. The surgeon removes the bladder and performs pelvic lymph-node dissection according to the planned cancer operation.
The exact structures removed depend on the patient’s anatomy, tumour location and extent, and the oncological plan. The aim is to remove the cancer with appropriate margins while following established cancer-surgery principles.
After bladder removal, the surgeon creates the chosen urinary diversion. Depending on the patient and the team’s approach, reconstruction may be performed partly or entirely inside the abdomen. The type of diversion and the way it is constructed should be discussed before surgery.
Bladder removal is only one part of the operation. The new route for urine must be planned carefully because it affects recovery, day-to-day care and long-term urinary function.
An ileal conduit carries urine through a segment of intestine to a stoma on the abdomen, where it drains into an external pouch. An orthotopic neobladder is created from intestine and connected to the urethra in selected patients. Some patients with a neobladder need scheduled voiding or intermittent catheterisation.
The appropriate choice depends on cancer location, urethral involvement, kidney and bowel function, previous treatments, general health, ability to manage the diversion and the patient’s preferences. No diversion is best for everyone. Page 7 discusses neobladder versus ileal conduit in more detail.
Robotic-assisted and open radical cystectomy are different ways to perform the same major cancer operation. Robotic surgery uses small incisions and a camera-controlled instrument system; open surgery uses a larger incision to access the pelvis.
Potential advantages of a minimally invasive approach may include smaller skin incisions and, for some patients, less blood loss or a shorter recovery in selected aspects. However, results vary. Robotic surgery still involves major internal surgery, and complications can occur with either approach.
The most important questions are whether the operation can be performed safely and thoroughly, whether the surgeon and team have experience with the planned reconstruction, and whether the approach suits the individual cancer and patient. Robotic surgery should not be presented as automatically superior to open surgery.
Radical cystectomy is a complex operation involving cancer removal, lymph-node surgery and urinary reconstruction. Experience with the complete procedure—not just use of a robotic platform—is important.
Patients may wish to ask how often the surgeon performs radical cystectomy, what types of urinary diversion the team offers, how complications are monitored and managed, and what support is available after discharge.
Dr. Swati H. Shah has performed robotic uro-oncologic surgery since 2013, including robotic radical cystectomy and robotic neobladder reconstruction. Her practice includes complex pelvic cancer surgery and urinary reconstruction. The recommended approach for each patient depends on the clinical findings and individual suitability.
Preparation may include review of the TURBT and histopathology reports, staging scans, blood tests, kidney-function assessment, anaesthesia review and evaluation of fitness for surgery. The oncology team will also discuss whether treatment before surgery is recommended.
Patients should tell the team about all medicines, allergies, previous operations and medical conditions. Do not stop blood-thinning medicines or other prescribed treatment without instructions from the treating team.
Preoperative counselling should cover the planned operation, possible removal of adjacent structures, urinary diversion choices, expected hospital stay, recovery, potential complications and the support needed at home. Stoma education may be arranged if an illegal conduit is planned.
Recovery varies according to the patient’s health, the extent of surgery, the urinary diversion and whether complications occur. During the hospital stay, the team monitors pain, mobility, bowel function, fluid balance, kidney function and the new urinary route.
After discharge, patients may need help with wound care, stoma management or neobladder training. Gradual activity, nutrition, hydration and follow-up should follow the individual care plan.
The final pathology report helps determine the cancer stage, lymph-node status, surgical margins and whether additional treatment should be discussed. Long-term follow-up is important to monitor cancer status, kidney function, urinary reconstruction and general recovery.
Robotic radical cystectomy is major surgery. Possible complications include bleeding, infection, blood clots, bowel complications, delayed bowel function, urine leakage, narrowing or blockage of the urinary drainage pathway, kidney problems and issues related to the stoma or neobladder.
Conversion to open surgery may occasionally be necessary for safety or technical reasons. A robotic approach does not guarantee fewer complications, complete cancer control or a faster recovery for every patient. Your surgical team should explain the risks that apply to your circumstances.
Dr. Swati H. Shah is a uro- and gynaecologic oncosurgeon practising at Apollo Hospital, Ahmedabad, and Shah’s Cancer & Robotic Surgery Centre, Gota. Her work includes robotic uro-oncologic surgery, radical cystectomy, pelvic lymph-node dissection and urinary reconstruction, including selected neobladder procedures.
Patients considering robotic cystectomy should receive a personalised assessment of the cancer stage, suitability for systemic treatment, overall fitness, possible urinary diversions and the benefits and limitations of robotic and open approaches. A consultation can help clarify the recommended sequence of treatment and what recovery may involve.
No. The surgeon controls the robotic instruments throughout the operation.
It uses small incisions for the camera and instruments, but it remains a major operation involving bladder removal and urinary reconstruction.
No. The best approach depends on the patient, cancer, reconstruction plan and surgical team’s expertise.
It may be possible in selected patients. Suitability depends on cancer-related factors, anatomy, kidney and bowel function, and the patient’s ability to manage the reconstruction.
Some patients are advised to receive systemic treatment before cystectomy. Eligibility and the recommended regimen should be assessed by the oncology team.
Recovery differs between patients and depends on the operation, urinary diversion, overall health and any complications. Your team can provide an individual estimate.
A 69-year-old male presented with intermittent, visible blood in his urine, a classic warning sign of underlying bladder pathology. Diagnostic imaging identified a 2 cm mass located on the right lateral wall, necessitating a precise intervention to both treat the lesion and obtain a definitive tissue diagnosis for staging.
⦿ Transurethral Resection of Bladder Tumor (TURBT)
• Procedure: Performed a complete endoscopic resection of the 2 cm right lateral bladder wall tumor.
• Staging Accuracy: Captured a targeted deep muscle biopsy to accurately determine the depth of tumor invasion.
• Safety / Blood Loss: Achieved successful intraoperative hemostasis, ensuring the patient remained hemodynamically stable throughout the procedure.
• Functional Preservation: Integrated a Double J stent placement to safeguard kidney function and maintain smooth urinary flow.
⦿ Rapid Recovery and Early Ambulation
The patient’s recovery was immediate and uneventful, with pain levels expertly managed through minimally invasive protocols. He was fully ambulatory and ready for discharge within just 24 hours of the procedure, returning home in stable condition. This proactive surgical intervention provided both a functional cure for the hematuria and a critical pathological roadmap for his future surveillance.
Visible blood in urine is a signal that demands immediate action. Through this minimally invasive endoscopic approach, we were able to completely remove the tumor and provide accurate staging, allowing this patient to return to his daily life almost immediately while securing a clear path for long-term monitoring.
With robotic surgery, the surgeon operates using a high-definition 3D, magnified view and specialized instruments that provide enhanced dexterity and precision. This can be particularly valuable during complex pelvic cancer surgery, where careful dissection is required around major blood vessels, nerves and other critical structures.
The procedure shown demonstrates meticulous removal of the bladder and lymph nodes as part of comprehensive cancer surgery. Robotic minimally invasive surgery may offer potential benefits such as smaller incisions, reduced blood loss, less postoperative discomfort and earlier recovery, although the suitability and benefits vary according to the cancer stage, anatomy and overall health of each patient.
Every bladder cancer patient requires an individualized treatment plan based on the tumour characteristics and stage.
In conventional laparoscopic surgery, the surgeon operates while looking at a monitor and directly controls long, rigid instruments. In robotic surgery, the surgeon sits at a console and controls the robotic instruments and camera with precise hand movements.
One important advantage of robotic surgery is enhanced visualization. The surgeon can control the camera, obtain a high-definition 3D view, and magnify the operating field up to 10×, depending on the system and procedure. This can help identify important anatomical structures more clearly.
Robotic instruments are also highly flexible and can rotate through a wide range of motion, allowing precise movements even in deep or confined anatomical spaces. This can be particularly useful for complex cancer operations where meticulous dissection is required.
This video features a patient testimonial and educational insight from Dr. Swati Shah, a renowned Robotic Uro-Oncologist and Gynecologic Cancer Surgeon. The primary focus of the video is on “Robotic Cystectomy with Neobladder,” a highly advanced surgical procedure used to treat urinary bladder cancer. When a patient’s urinary bladder is entirely removed due to cancer (a procedure called a cystectomy), a major concern is how they will pass urine afterward. The video addresses this critical question by explaining the concept of a “neobladder”—a new bladder surgically created from the patient’s own intestine, allowing them to urinate naturally without the need for an external stoma bag.
The video features a heartwarming and positive patient testimonial dedicated to Dr. Swati Shah, a highly regarded Robotic Uro-Oncologist and Gynecological Cancer Surgeon. It highlights the successful treatment of an elderly patient, who traveled from Kotvada village in the Bhavnagar district of Gujarat to seek specialized medical care. He recently underwent a complex Radical Cystectomy—a major surgical procedure to remove the urinary bladder—for the treatment of urinary bladder cancer under the expert supervision of Dr. Shah at Apollo Hospital. In the brief clip, the patient’s nephew shares their medical journey, explaining that they discovered Dr. Swati Shah’s profile online while searching for the best possible urological cancer treatment.
This video features a heartfelt patient testimonial detailing a successful bladder cancer surgery performed by Dr. Swati Shah, a highly skilled Robotic Uro-Oncologist. In the clip, a patient shares their personal recovery journey following a complex Robotic Radical Cystectomy, a major procedure where a new urinary bladder, known as a neobladder, was surgically created using advanced robotic technology. The patient explains that they underwent this operation two months prior. Although they initially felt anxious and fearful about the potential complications of such a significant medical procedure, the modern robotic approach and Dr. Shah’s expertise made the experience remarkably smooth.
This page provides general educational information and does not replace an individual medical consultation. Robotic surgery is not suitable for every patient. Treatment decisions should be made with the treating team after reviewing the diagnosis, staging, general health and patient preferences.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.